Analysts are weighing in on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and Israeli pharma company Oramed Pharmaceuticals, Inc.
Maxim’s healthcare analyst Jason Kolbert weighted in today on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and stem cell research company StemCells Inc (NASDAQ:STEM).
By Terry Chrisomalis Anavex Life Sciences Corp On November 9, 2015 Anavex Life Sciences Corp. (NASDAQ:AVXL) reported positive phase 2a results for the …
